Despite the widespread usage of mdx mice in DMD research, this animal model exhibits limitations, such as a milder muscle pathology and compensatory upregulation of genes like utrophin,[47] which complicate the evaluation of therapeutic interventions. This evidence concerns the gene UTRN and Duchenne muscular dystrophy.